Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a cultural interview keep patients in mental health care?

NCT ID NCT03044145

Knowledge-focused Sponsor: New York State Psychiatric Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a tool called the Cultural Formulation Interview-Engagement Aid (CFI-EA), designed to help clinicians and patients from different cultural backgrounds communicate better. The goal is to see if using this tool improves patient satisfaction and keeps people in treatment longer. The study involves adult patients and clinicians at a mental health clinic, comparing the tool to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cultural Formulation Interview-Engagement Aid
What this could lead to
If effective, this tool could help mental health clinicians tailor care to patients' cultural needs, potentially improving treatment retention and outcomes.
What could go wrong
This is a small, early-stage pilot study. The tool may not show clear benefits, or results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Sep 2016

Finished

Sep 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For Project 1 Inclusion Criteria: * Male and female patients aged 18-80; Method of ascertainment: Self-report. * New patients at JHMC, referred by the intake coordinator; Method of ascertainment: Intake coordinator. * Willingness and ability to provide written informed consent after full explanation of study procedures. Method of ascertainment: RA informed consent interview that includes a capacity to consent screening form; Clinician referral. * Racial and ethnic minority (African-American, Latino/Hispanic, Asian-American/Pacific Islander, and Native American). Method of ascertainment: Self-report Exclusion Criteria: * Actively suicidal or homicidal; Method of ascertainment: Self-report and clinician evaluation * In need of acute detoxification services; Method of ascertainment: Self-report and clinician evaluation * A condition that interferes with participation (i.e., dementia, mental retardation, or florid psychosis); Method of ascertainment: Clinician evaluation; patients ≥ 65 years of age will participate in a mini-cog exam. * Caucasian race; Method of ascertainment: self-report For Project 2 Inclusion Criteria: * Male and female patients aged 18-80; Method of ascertainment: Self-report. * New patients at JHMC, referred by the intake coordinator; Method of ascertainment: Intake coordinator. * Willingness and ability to provide written informed consent after full explanation of study procedures. Method of ascertainment: RA informed consent interview that includes a capacity to consent screening form; Clinician referral. * Racial and ethnic minority (African-American, Latino/Hispanic, Asian-American/Pacific Islander, and Native American). Method of ascertainment: Self-report Exclusion Criteria: * Actively suicidal or homicidal; Method of ascertainment: Self-report and clinician evaluation * In need of acute detoxification services; Method of ascertainment: Self-report and clinician evaluation * A condition that interferes with participation (i.e., dementia, mental retardation, or florid psychosis); Method of ascertainment: Clinician evaluation; patients ≥ 65 years of age will participate in a mini-cog exam. * Caucasian race; Method of ascertainment: self-report * Patients in Project 1 will be excluded from Participation in Project 2: Method of assessment: self-report and PI/RA evaluation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, patient are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Communication communication disorder Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, patient Communication

Contacts and locations

Locations

  • Flushing Hospital Medical Center

    Flushing, New York, 11355, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.